Submitted:
12 June 2024
Posted:
13 June 2024
You are already at the latest version
Abstract
Keywords:
Introduction
Materials and Methods
Data Collection Forms
Statistical Analysis
Results
Discussion
Strengths and Limitations of the Study
Conclusion
Conflict of Interest:
References
- World Health Organization. Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer. (accessed on 19 January 2023).
- TUİK ölüm ve ölüm nedeni istatistikleri 2019. Erişim adresi: https://data.tuik.gov.tr/Bulten/Index?p=Olum-ve-Olum-Nedeni-Istatistikleri-2019-33710. Erişim Tarihi: 07.12.2021.
- Cancer today. Erişim adresi: https://gco.iarc.fr/today/home. Erişim Tarihi: 07.12. 2021.
- Cancer tomorrow. Erişim adresi: https://gco.iarc.fr/tomorrow/en. Erişim Tarihi: 07.12. 2021.
- SEER, C.S.F. Testicular Cancer. 2019: National Cancer Institute.
- Moul, J.W.; Paulson, D.F.; Dodge, R.K.; Walther, P.J. Delay in Diagnosis and Survival in Testicular Cancer: Impact of Effective Therapy and Changes During 18 Years. J. Urol. 1990, 143, 520–523. [Google Scholar] [CrossRef]
- Lechner, L.; Oenema, A.; de Nooijer, J. Testicular self-examination (TSE) among Dutch young men aged 15-19: determinants of the intention to practice TSE. Heal. Educ. Res. 2002, 17, 73–84. [Google Scholar] [CrossRef]
- Moul, J.W. Timely Diagnosis of Testicular Cancer. Urol. Clin. North Am. 2007, 34, 109–117. [Google Scholar] [CrossRef]
- Post, G.J.; Belis, J.A. Delayed Presentation of Testicular Tumors. South. Med J. 1980, 73, 33–34. [Google Scholar] [CrossRef]
- YALÇINKAYA, U. , et al., Testis tümörleri: 30 yıllık arşiv tarama sonuçları. Türk Patoloji Dergisi, 2008. 24(2): p. 100-106.
- Yılmaz, E., A. Kutlu, and D. Çeçen, Sağlık yüksekokulu öğrencilerinin testis kanseri ve kendi kendine testis muayenesi ile ilgili bilgi, tutum ve davranışları. Fırat Sağlık Hizmetleri Dergisi, 2009. 4(10): p. 72-85.
- Uyar, M.; Yıldırım, E.N.; Kemal, T. Evaluation of Testicular Self-examination Technique and Testis Cancer Knowledge Levels of Final-year Medical Students. Bull. Urooncology 2019, 18, 10–13. [Google Scholar] [CrossRef]
- Testiculer screening. Erişim adresi: https://www.cancer.gov/types/testicular/patient/testicular-screening-pdq. Erişim Tarihi: 11.12. 2021.
- Kuzgunbay, B.; Yaycioglu, O.; Soyupak, B.; Kayis, A.A.; Ayan, S.; Yavascaoglu, I.; Cal, C.; Beduk, Y. Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society. Urol. Oncol. Semin. Orig. Investig. 2013, 31, 386–391. [Google Scholar] [CrossRef]
- Altın, R. and S. Kav, Üniversite öğrencilerinde TK ve kendi kendine testis muayenesiyle ilgili bilgi ve davranışları. 2007, Uluslararası.
- Daley, C.M. College Men's Knowledge, Attitudes, and Beliefs About Testicular Cancer. Am. J. Men's Heal. 2007, 1, 173–182. [Google Scholar] [CrossRef]
- Ugwumba, F.; Ekwueme, O.E.C.; Okoh, A.D. Testicular Cancer and Testicular Self-Examination; Knowledge, Attitudes and Practice in Final Year Medical Students in Nigeria. 2016, 17, 4999–5003. [CrossRef]
- Türkiye Kanser İstatikleri-2016. Erişim adresi: https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri/yillar/2016-yili-turkiye-kanser-i-statistikleri.html. Erişim Tarihi: 13.12. 2021.
- Bektaş, M. , et al., Hemşirelik öğrencilerinin kendi kendine meme muayenesi, kendi kendine testis muayenesi ile HPV aşısı hakkında bilgi ve uygulamaları. Yıldırım Beyazıt Üniversitesi Sağlık Bilimleri Fakültesi Hemşirelik E-Dergisi, 2014. 2(2): p. 1-11.
- Altınel, B. and İA Aydın, Üniversite öğrencilerinin testis kanseri ve kendi kendine testis muayenesi hakkındaki bilgi, inanç ve uygulamaları. TSK Koruyucu Hekimlik Bülteni, 2013. 12(4): p. 365-370.
- Göçgeldi, E. and N. Koçak, Evaluation of the education given to the young adult males about testicular self examination. Gülhane Tip Dergisi, 2010. 52(4): p. 270.
- Frank, E. and L.K. Harvey, Prevention advice rates of women and men physicians. Archives of Family Medicine, 1996. 5(4): p. 215-220.
| Variables | Categories | n | % | |||
|---|---|---|---|---|---|---|
| Gender | Female | 138 | 45.0 | |||
| Male | 169 | 55.0 | ||||
| Age (years) (Mean ± SS, Min-Max)* | 30.54±6.01 | (24.00-60.00) | ||||
| Age category | 24-40 years 41-60 years |
288 19 |
93.8 6.2 |
|||
| Marital status | Married | 169 | 55.0 | |||
| Single | 138 | 45.0 | ||||
| Profession | Family medicine | 32 | 10.4 | |||
| General practitioner | 26 | 8.5 | ||||
| SAHU | 42 | 13.7 | ||||
| Family medicine resident | 207 | 67.4 | ||||
| Instituion | ASM(Family Health Center) | 78 | 25.4 | |||
| TSM(Community Health Center) | 4 | 1.3 | ||||
| Medical faculty | 73 | 23.8 | ||||
| City Hospital | 125 | 40.7 | ||||
| Training and Research hospital | 23 | 7.5 | ||||
| Other | 4 | 1.3 | ||||
| Years in profession (years) (Mean ± SS, Min-Max)* | 5.93±5.89 | (0.00-37.00) | ||||
| n | % | |
|---|---|---|
| Are you adequately knowledgeable about testicular cancers? | ||
| Yes | 6 | 2.0 |
| Partially | 202 | 65.8 |
| No | 99 | 32.2 |
| What is the most common age range for testicular cancers? | ||
| 0-15 years | 26 | 8.5 |
| 16-35 years | 157 | 51.1 |
| 36-55 years | 35 | 11.4 |
| Over 55 years | 33 | 10.7 |
| I don’t know | 56 | 18.3 |
| What are the risk factors for testicular cancer? * | ||
| Family history | 286 | 93.2 |
| Genetic predisposition | 289 | 94.1 |
| Age | 236 | 76.9 |
| Mumps infection | 137 | 44.6 |
| Cryptorchidism | 196 | 63.8 |
| Estrogen use during pregnancy | 120 | 39.1 |
| All | 113 | 36.8 |
| I don’t know | 12 | 3.9 |
| What is the most common risk factor for testicular cancer? | ||
| Family history | 78 | 25.4 |
| Genetic predisposition | 92 | 30.0 |
| Cryptorchidism | 70 | 22.8 |
| I don’t know | 67 | 21.8 |
| Gender n (%) ** | |||||
|---|---|---|---|---|---|
| Characteristic | Female(n=138) n (%) |
Male(n=169) n (%) |
χ2*** | p | |
| Educational Video | |||||
| Yes | 1 (0.7) | 19 (11.2)* | 13.799 | <0.001 | |
| No | 137 (99.3) | 148 (88.8) | |||
| Reading Informative Sources | |||||
| Yes | 23 (16.7) | 64 (37.9)* | 15.818 | <0.001 | |
| No | 115 (83.3) | 105 (62.1) | |||
| Education | |||||
| Received different Education | 32 (23.2) | 81 (47.9) | 19.991 | <0.001 | |
| Did not receive different education | 106 (76.8) * | 88 (52.1) | |||
| Adequate Knowledge Level | |||||
| Yes / Partially | 84 (60.9) | 124 (73.4) * | 5.436 | 0.020 | |
| No | 54 (39.1) | 45 (26.6) | |||
| Testis Ca Risk Factors | |||||
| I don’t know | 10 (7.2) | 2 (1.2) | 7.435 | 0.006 | |
| I am aware | 128 (92.8) | 167 (98.8)* | |||
| Reading Informative Sources on TSE | |||||
| Yes | 16 (11.9) | 39 (23.1)* | 6.811 | 0.009 | |
| No | 122 (88.4) | 130 (76.9) | |||
| TSE Education | |||||
| Received different education | 24 (17.4) | 53 (31.4)* | 7.890 | 0.005 | |
| Did not receive different education | 114 (82.6) | 116 (68.6) | |||
| Knowledge of how to perform TSE | |||||
| Yes / Partially | 42 (30.4) | 88 (52.1)* | 14.566 | <0.001 | |
| No | 96 (69.6) | 81 (47.9) | |||
| Perception of Testicular Examination as Beneficial | |||||
| Yes | 137 (99.3)* | 157 (92.9) | 7.616 | 0.006 | |
| No | 1 (0.7) | 12 (7.1) | |||
| Marital Status** | ||||||
|---|---|---|---|---|---|---|
| Characteristic | Married(n=169) n (%) |
Single(n=138) n (%) |
χ2*** | p | ||
| Testicular Cancer Patient Follow-up | ||||||
| Yes | 52 (30.8)* | 28 (20.3) | 4.330 | 0.037 | ||
| No | 117 (69.2) | 110 (79.7) | ||||
| Family History of Testicular Cancer | ||||||
| Yes | 17 (10.1)* | 2 (1.4) | 9.700 | 0.002 | ||
| No | 152 (89.9) | 136 (98.6) | ||||
| Attendance to Presentations on TSE | ||||||
| Yes | 9 (5.3) | 17 (12.3)* | 4.793 | 0.029 | ||
| No | 160 (94.7) | 121 (87.7) | ||||
| Age Category (years)** | 24-40 (n=288) n (%) |
41-60 (n=19) n (%) |
||||
| Attendance to Education Presentations | ||||||
| Yes | 23 (8.0) | 6 (31.6)* | 11.599 | 0.005 | ||
| No | 265 (92.0) | 13 (68.4) | ||||
| Title ** | |||||
|---|---|---|---|---|---|
| Characteristic | Specialist (n=32) n (%) | Practitioner (n=26)n (%) | Resident (n=249) n (%) | χ2*** | p |
| Testicular Cancer Patient Follow-up | |||||
| Yes | 16 (50.0) | 8 (30.8) | 56 (22.5)* | 11.465 | 0.003 |
| No | 16 (50.0) | 18 (69.2) | 193 (77.5) | ||
| Is Mumps Infection a Risk for Testicular Cancer? | |||||
| Yes | 24 (75.0)* | 9 (34.6) | 104 (41.8) | 13.825 | 0.001 |
| No | 8 (25.0) | 17 (65.4) | 145 (58.2) | ||
| Is Estrogen Use during Pregnancy a Risk for Testicular Cancer? | |||||
| Yes | 21 (65.6)* | 8 (30.8) | 91 (36.5) | 10.896 | 0.004 |
| No | 11 (34.4) | 18 (69.2) | 158 (63.5) | ||
| Are all factors risks for testicular cancer? | |||||
| Yes | 21 (65.6)* | 8 (30.8) | 84 (33.7) | 12.843 | 0.002 |
| No | 11 (34.4) | 18 (69.2) | 165 (66.3) | ||
| Is Gynecomastia a symptom of testicular cancer? | |||||
| Yes | 22 (68.8)* | 15 (57.7) | 105 (42.2) | 9.554 | 0.008 |
| No | 10 (31.2) | 11 (42.3) | 144 (57.8) | ||
| Is Hematuria a symptom of testicular cancer? | |||||
| Yes | 22 (68.8)* | 12 (46.2) | 104 (41.8) | 8.360 | 0.015 |
| No | 10 (31.2) | 14 (53.8) | 145 (58.2) | ||
| Is Abdominal Pain a symptom of testicular cancer? | |||||
| Yes | 22 (68.8)* | 15 (57.7) | 99 (39.8) | 11.723 | 0.003 |
| No | 10 (31.2) | 11 (42.3) | 150 (60.2) | ||
| Are all symptoms indicative of testicular cancer? | |||||
| Yes | 22 (68.8)* | 11 (42.3) | 79 (31.7) | 17.189 | <0.001 |
| No | 10 (31.2) | 15 (57.7) | 170 (68.3) | ||
| TSE Education | |||||
| Received at least one different education | 14 (43.2)* | 6 (23.1) | 57 (22.9) | 6.626 | 0.036 |
| Did not receive any different education | 18 (56.3) | 20 (76.9) | 192 (77.1) | ||
| Family cancer history ** | ||||
|---|---|---|---|---|
| Feature | Present(n=19) n (%) |
Absent(n=288) n (%) |
χ2*** | p |
| Attendance to educational presentation | ||||
| Yes | 6 (31.6)* | 23 (8.0) | 11.599 | 0.005 |
| No | 13 (68.4) | 265 (92.0) | ||
| Information source reading | ||||
| Yes | 11 (57.9)* | 76 (26.4) | 8.712 | 0.003 |
| No | 8 (42.1) | 212 (73.6) | ||
| Education | ||||
| Received at least one different education | 16 (84.2)* | 97 (33.7) | 19.566 | <0.001 |
| Did not receive any different education | 3 (15.8) | 191 (66.3) | ||
| Adequate knowledge level | ||||
| Yes | - | 6 (2.1) | ||
| No | 2 (10.5) | 97 (33.7) | 4.374 | 0.036 |
| Partially | 17 (89.5)* | 185 (64.2) | ||
| TSE Information Source Reading | ||||
| Yes | 10 (52.6)* | 45 (15.6) | 16.599 | <0.001 |
| No | 9 (47.4) | 243 (84.4) | ||
| TSE Education | ||||
| Received at least one different education | 13 (68.4)* | 64 (22.2) | 20.245 | <0.001 |
| Did not receive any different education | 6 (31.6) | 224 (77.8) | ||
| Testicular Cancer Follow-up ** | ||||
|---|---|---|---|---|
| Feature | Present(n=80) n (%) |
Absent (n=227) n (%) |
χ2*** | p |
| Informative source reading | ||||
| Yes | 32 (40.0) | 55 (24.2) | 7.245 | 0.007 |
| No | 48 (60.0) | 172 (75.8) * | ||
| Education | ||||
| Received different education | 39 (48.8) | 74 (32.6) | 6.634 | 0.010 |
| No different education | 41 (51.3) | 153 (67.4) * | ||
| Adequate knowledge level | ||||
| Yes | 1 (1.3) | 5 (2.2) | ||
| No | 16 (20.0) | 83 (36.6) | 7.428 | 0.006 |
| Partially | 63 (78.8)* | 139 (61.2) | ||
| TSE informative source reading | ||||
| Yes | 23 (28.8)* | 32 (14.1) | 8.637 | 0.003 |
| No | 57 (71.2) | 195 (85.9) | ||
| Regular testicular examination | ||||
| Beneficial | 80 (100.0) | 214 (94.3) | ||
| No beneficial | - | 13 (5.7) | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).